Ypsomed expands the mylife(TM) Diabetescare product range

The new mylife(TM) Roto(TM) infusion set with 360-degree freedom of movement

Burgdorf, (PresseBox) - Ypsomed is launching a new infusion set on the German market for anyone with diabetes who uses an insulin pump with a luer-lock connection: the mylife(TM) Roto(TM) with 360-degree freedom of movement. Unlike conventional infusion systems, the infusion tube in the mylife(TM) Roto(TM) rotates 360 degrees, offering maximum freedom of movement for the insulin pump carrier. The mylife(TM) Roto(TM) infusion system is a perfect addition to Ypsomed's existing mylife(TM) Diabetescare product portfolio, which includes mylife(TM) Penfine®, Clickfine® and Clickfine® AutoProtect(TM) needles, mylife(TM) Pura® blood glucose meter systems and the mylife(TM) OmniPod® insulin patch pump.

Simon Michel, Senior Vice President Marketing & Sales, is enthusiastic: "Because of the 360-degree rotational freedom of its infusion tube, the mylife(TM) Roto(TM) infusion set is ideal for an active lifestyle. With mylife(TM) Rotosoft(TM) and mylife(TM) Rotofine(TM) , we are enhancing the mylife(TM) Diabetescare product portfolio from Ypsomed and offering our customers greater freedom in their lives." Another bonus is that mylife(TM) Roto(TM) is so inconspicuous. The tape is semi-transparent, and the set itself has a very low profile with a height of only six millimetres. The set is also easy to attach and user-friendly. Selecting the infusion site is just as simple, and the set can be connected and disconnected easily in any position. A click indicates that everything is correctly fitted into place, providing the patient with the security required. In addition, the mylife(TM) Roto(TM) infusion set is attached using an innovative, heat-activated tape that ensures it is held securely.

mylife(TM) Roto(TM) is now available in Germany in two versions: the mylife(TM) Rotosoft(TM) has a flexible Teflon catheter, which is one of the smallest of its kind on the market and offers maximum comfort during use. The mylife(TM) Rotofine(TM) has a high-quality steel cannula, which is also one of the thinnest and shortest steel cannulas currently available on the market.

You can find more information about mylife(TM) Roto(TM) at www.mylife-diabetescare.com.

Ypsomed AG

The Ypsomed Group is the leading independent developer and manufacturer of injection systems for self-medication and a recognised diabetes specialist with more than 25 years' experience. The Ypsomed Group, which emerged in 2003 from the well-known Disetronic Group, today offers insulin pumps, injection systems and pen needles for diabetes, growth hormone and infertility treatments as well as for other therapeutic fields. Ypsomed is an innovation and technology leader with an extensive patent portfolio and is the preferred partner of pharmaceutical and biotech companies in the self-medication sector. The Ypsomed Group has its headquarters in Burgdorf, Switzerland. It has several manufacturing sites in Switzerland as well as specialist diabetes marketing companies throughout Europe. The Ypsomed Group employs a staff of approximately 1,150.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.